Prognostic impact of minimal residual disease analysis by flow cytometry in patients with acute myeloid leukemia before and after allogeneic hemopoietic stem cell transplantation.

MLA

Bastos, Oreiro, Mariana, et al. “Prognostic Impact of Minimal Residual Disease Analysis by Flow Cytometry in Patients with Acute Myeloid Leukemia before and after Allogeneic Hemopoietic Stem Cell Transplantation.” European Journal of Haematology, vol. 93, no. 3, Sept. 2014, pp. 239–46. EBSCOhost, https://doi.org/10.1111/ejh.12336.

APA

Bastos, O. M., Perez, C. A., Martínez, L. C., Bento, L., Pascual, C., Kwon, M., Balsalobre, P., Muñoz, C., Buces, E., Serrano, D., Gayoso, J., Buño, I., Anguita, J., & Diéz, M. J. L. (2014). Prognostic impact of minimal residual disease analysis by flow cytometry in patients with acute myeloid leukemia before and after allogeneic hemopoietic stem cell transplantation. European Journal of Haematology, 93(3), 239–246. https://doi.org/10.1111/ejh.12336

Chicago

Bastos, Oreiro, Mariana, Corral, Ana Perez, Laperche, Carolina Martínez, Leyre Bento, Cristina Pascual, Mi Kwon, Pascual Balsalobre, et al. 2014. “Prognostic Impact of Minimal Residual Disease Analysis by Flow Cytometry in Patients with Acute Myeloid Leukemia before and after Allogeneic Hemopoietic Stem Cell Transplantation.” European Journal of Haematology 93 (3): 239–46. doi:10.1111/ejh.12336.